With nearly $4.2B raised, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies, focusing on Life Sciences and Growth Buyout investments.

Life Sciences

Acquired by AstraZeneca in 2016
IPO in 2017 (NASDAQ: ANAB)
Acquired by Valeant Pharmaceuticals in 2014
Acquired by Allergan in 2016

Growth Buyout

Acquired by Tailwind Capital
Acquired by The Partners Group

News

Abode Healthcare

Tailwind Capital Acquires Abode Healthcare

ARMO Biosciences

Lilly Completes Acquisition of ARMO BioSciences

Frazier Healthcare Partners

Frazier Healthcare Partners Closes Oversubscribed $780 Million Growth Buyout Fund

Frazier Healthcare Partners

Frazier Healthcare Partners Closes Oversubscribed $419 Million Life Sciences Fund